(Q39121484)

9 September 2017

The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study (English)

1 reference

9 September 2017

0 references

1 reference

1 reference

J Antonio Aviña-Zubieta

1

1 reference

9 September 2017

Vidula M Bhole

2

1 reference

9 September 2017

Neda Amiri

3

1 reference

9 September 2017

Eric C Sayre

4

1 reference

9 September 2017

Hyon K Choi

5

1 reference

9 September 2017

language of work or name

English

0 references

publication date

29 September 2014

1 reference

Annals of the Rheumatic Diseases

9 September 2017

1 reference

9 September 2017

75

1 reference

9 September 2017

1

1 reference

9 September 2017

148-154

1 reference

Effect of antiplatelet/anticoagulant therapy on severe ischemic complications in patients with giant cell arteritis: a cumulative meta-analysis.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: a cohort study

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

The role of coagulation in chronic inflammatory disorders: a jack of all trades

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Risk factors for venous and arterial thrombosis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Inflammation, innate immunity and blood coagulation.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Competing risk regression models for epidemiologic data

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Increased risk of peripheral arterial disease in polymyalgia rheumatica: a population-based cohort study

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Antiplatelet and anticoagulant therapy in patients with giant cell arteritis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Giant-cell arteritis and polymyalgia rheumatica

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Giant cell arteritis of coronary arteries causing myocardial infarction

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Oral fluoroquinolones and the risk of retinal detachment

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Incidence of infections in patients with giant cell arteritis: a cohort study

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis: a population-based study

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Two cases of recurrent stroke in treated giant cell arteritis: diagnostic and therapeutic dilemmas

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Lethal giant cell arteritis with multiple ischemic strokes despite aggressive immunosuppressive therapy

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Role of thrombocytosis in diagnosis of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic optic neuropathy.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5587203

Use of Glucocorticoids and Risk of Venous Thromboembolism

21 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205665

Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2014-205665

Risk factors for venous thromboembolism

21 January 2018

1 reference

12 December 2020

Thrombocytosis and giant cell arteritis

1 reference

12 December 2020

Incidence and mortality of venous thrombosis: a population-based study

1 reference

12 December 2020

Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom

1 reference

12 December 2020

Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases

1 reference

12 December 2020

Coronary giant cell arteritis and acute myocardial infarction

1 reference

12 December 2020

Implications of thrombocytosis in giant cell arteritis

1 reference

12 December 2020

Thrombocytosis in patients with biopsy-proven giant cell arteritis

1 reference

12 December 2020

Risk factors for thrombotic events in giant cell arteritis and polymyalgia rheumatica

1 reference

12 December 2020

10.1136/ANNRHEUMDIS-2014-205665

Identifiers

DOI

1 reference

9 September 2017

1 reference

9 September 2017

PubMed publication ID

25265937

1 reference